Monday, June 15, 2026

TSMC Plans $100 Billion U.S. Investment as It Expands Manufacturing in Arizona

TSMC plans a $100 billion U.S. investment amid tariff concerns, expanding its Arizona operations and aiming for advanced chip production.

Is ADOR Lying? Shin Woo Seok Drops Bombshell with Proof of Dishonesty

Shin accused ADOR's CEO Kim Joo Young and Vice President Lee Do Kyung of dishonesty, asserting that he has evidence ...

Gwyneth Paltrow Brings Korean Nature to Life in New York’s Genesis House

Gwyneth Paltrow's immersive exhibition celebrates Korean forests, blending wellness and cultural storytelling in Manhattan.

Tag: cancer

HLB Group Maps Commercialization Push as It Awaits Key U.S. Cancer Drug Decisions

HLB Group seeks FDA approval for cancer drugs, aiming for global impact through innovation and collaboration in the biotech sector.

Seoul St. Mary’s Hospital Reaches 20,000 Robotic Surgeries, Marking New Clinical Milestone

Seoul St. Mary's Hospital celebrates 20,000 robotic surgeries, enhancing patient care with advanced single-port techniques for various conditions.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

GreenVet Announces CaniCancer-FFPE, a Precision Cancer Diagnostic Solution for Pets

GreenVet introduces CaniCancer, a unified cancer diagnostic solution for pets, streamlining biopsy and genetic testing for faster treatment.

Microgravity in Space May Revolutionize How Biopharmaceuticals Form and Function within the Body

Space's microgravity could transform biopharmaceuticals, enabling new treatments and technologies for diseases, emphasizing long-term research.

How to Detect Bile Duct Cancer: Jaundice, Itching, Abdominal Pain, and Weight Loss

Cholangiocarcinoma, or bile duct cancer, has a poor prognosis due to late detection; early diagnosis is crucial for better outcomes.

GIST Maps Out the Cascade of Cellular Interactions During Early Stages of Lung Cancer

South Korean researchers unveil how mutated cells create a cancer-friendly environment in early lung cancer, paving the way for early interventions.

SCL Group Partners with Indonesian Hospital to Expand Into Southeast Asia

SCL Group partners with Indonesia's RSCM Hospital to expand Korean-style precision diagnostics in Southeast Asia, focusing on cancer screening and AI solutions.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Top News

- Our Sponsors Ad -

Follow us